Abstract
Three structurally defined QS-21-based immune adjuvant candidates (2a-2c) have been synthesized. Application of the two-stage activation glycosylation approach utilizing allyl glycoside building blocks improved the synthetic accessibility of the new adjuvants. The efficient synthesis and establishment of the stand-alone adjuvanticity of the examined synthetic adjuvant (2b) open the door to the pursuit of a new series of structurally defined QS-saponin-based synthetic adjuvants.
Original language | English |
---|---|
Pages (from-to) | 11525-11534 |
Number of pages | 10 |
Journal | Journal of Organic Chemistry |
Volume | 78 |
Issue number | 22 |
DOIs | |
Publication status | Published - 15 Nov 2013 |
Externally published | Yes |